Synonyms: | Benzoic acid,2-(4-hydroxybenzoyl)-,compd. with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1);Benzoic acid, o-(p-hydroxybenzoyl)-, compd. with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1);Asverin H;3-(dithiophen-2-ylmethylidene)-1-methyl-2,4,5,6-tetrahydropyridine; 2-(4-hydroxybenzoyl)benzoate;Asverin (TN);o-(p-Hydroxybenzoyl)benzoic acid, compound with 3-(di-2-thienylmethylene)-1-methylpiperidine (1:1);BENZOIC ACID, o-(p-HYDROXYBENZOYL)-, compd. with 3-(DI-2-THIENYLMETHYLENE)-1-MET;Tipepidine hibenzate (JP14); |
InChI: | InChI=1/C15H17NS2.C14H10O4/c1-16-8-2-5-12(11-16)15(13-6-3-9-17-13)14-7-4-10-18-14;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h3-4,6-7,9-10H,2,5,8,11H2,1H3;1-8,15H,(H,17,18) |
Specification: |
The cas register number of Tipepidine hibenzate is 31139-87-4. It also can be called as 3-[Di(thiophen-2-yl)methylidene]-1-methylpiperidin-1-ium 2-(4-hydroxybenzoyl)benzoate (1:1) and the IUPAC Name about this chemical is 3-(dithiophen-2-ylmethylidene)-1-methylpiperidine; 2-(4-hydroxybenzoyl)benzoic acid. Classification Code about this chemical is Drug / Therapeutic Agent.
Physical properties about Tipepidine hibenzate are: (1)ACD/LogP: 5.01; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 2.43; (4)ACD/LogD (pH 7.4): 4.12; (5)ACD/BCF (pH 5.5): 9.94; (6)ACD/BCF (pH 7.4): 485.57; (7)ACD/KOC (pH 5.5): 33.36; (8)ACD/KOC (pH 7.4): 1629.1; (9)#H bond acceptors: 1; (10)#Freely Rotating Bonds: 2; (11)Polar Surface Area: 56.48Å2; (12)Flash Point: 197.5 °C; (13)Enthalpy of Vaporization: 65.42 kJ/mol; (14)Boiling Point: 403 °C at 760 mmHg; (15)Vapour Pressure: 1.05E-06 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: [O-]C(=O)c1ccccc1C(=O)c2ccc(O)cc2.s1cccc1/C(c2sccc2)=C3\CCC[NH+](C)C3
(2)InChI: InChI=1/C15H17NS2.C14H10O4/c1-16-8-2-5-12(11-16)15(13-6-3-9-17-13)14-7-4-10-18-14;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h3-4,6-7,9-10H,2,5,8,11H2,1H3;1-8,15H,(H,17,18)
(3)InChIKey: KEEAAKGKVVTPOM-UHFFFAOYAX
(4)Std. InChI: InChI=1S/C15H17NS2.C14H10O4/c1-16-8-2-5-12(11-16)15(13-6-3-9-17-13)14-7-4-10-18-14;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h3-4,6-7,9-10H,2,5,8,11H2,1H3;1-8,15H,(H,17,18)
(5)Std. InChIKey: KEEAAKGKVVTPOM-UHFFFAOYSA-N
The toxicity data is as follows:
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intraperitoneal |
1440mg/kg (1440mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. |
mouse |
LD50 |
oral |
10gm/kg (10000mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 463, 1982. |
rat |
LD50 |
intraperitoneal |
1122mg/kg (1122mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. |
rat |
LD50 |
oral |
10gm/kg (10000mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 463, 1982. |
|